饮食诱导肥胖小鼠胰岛β细胞H3K27ac全基因组图谱揭示脂肪酸信号特征
该研究对饮食诱导肥胖(DIO)小鼠胰岛进行H3K27ac ChIP-Seq和RNA-Seq,发现39,350个顺式调控区中13,369个H3K27ac信号增加、4,610个减少,与基因表达全局变化显著相关。增加区域富集NRF1、GABPA和MEF2A基序,敲低这些因子可下调脂肪酸β氧化基因及相关H3K27ac。棕榈酸处理可诱导β氧化基因和H3K27ac增加,抑制上述因子后该反应减弱。
要点
- DIO小鼠胰岛H3K27ac增加主要位于近端启动子区,富集NRF1、GABPA、MEF2A基序。
- 敲低NRF1、GABPA或MEF2A可下调INS-1细胞脂肪酸β氧化基因及对应H3K27ac。
- 棕榈酸诱导的β氧化基因和H3K27ac增加在抑制上述因子后减弱。
核心结论
- DNA结合蛋白与脂肪酸信号在肥胖诱导的β细胞功能表观基因组调控中可能起新作用。
研究设计与样本
- 对饮食诱导肥胖(DIO)小鼠模型来源的胰岛进行H3K27ac ChIP-Seq和RNA-Seq,并用de novo motif分析差异H3K27ac区域富集的转录因子结合基序。
- 在INS-1大鼠β细胞系中用特异性siRNA进行功能缺失实验,分棕榈酸处理与未处理组,用ChIP和定量RT-PCR评估可能靶基因的表观基因组和转录变化。
主要发现
- 长期高脂饮食后C57BL/6J小鼠肥胖并轻度糖耐量异常。
- 39,350个胰岛顺式调控区域中,13,369和4,610个元素的ChIP-Seq信号分别增加和减少,与基因表达全局变化显著相关。
- 增加的H3K27ac主要位于近端启动子区域,de novo motif分析富集NRF1、GABPA和MEF2A元件;减少的H3K27ac富集MAFK,其为已知β细胞负调控因子。
- siRNA敲低NRF1、GABPA或MEF2A后,INS-1细胞脂肪酸β氧化基因下调,伴随相关H3K27ac减少。
- 棕榈酸处理引起H3K27ac增加和β氧化基因诱导,抑制NRF1、GABPA或MEF2A后这些反应减弱。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: Epigenetic regulation of gene expression has been implicated in the pathogenesis of obesity and type 2 diabetes. However, detailed information, such as key transcription factors in pancreatic beta cells that mediate environmental effects, is not yet available. METHODS: To analyse genome-wide cis-regulatory profiles and transcriptome of pancreatic islets derived from a diet-induced obesity (DIO) mouse model, we conducted chromatin immunoprecipitation coupled with high-throughput sequencing (ChIP-Seq) of histone H3 lysine 27 acetylation (histone H3K27ac) and high-throughput RNA sequencing. Transcription factor-binding motifs enriched in differential H3K27ac regions were examined by de novo motif analysis. For the predicted transcription factors, loss of function experiments were performed by transfecting specific siRNA in INS-1, a rat beta cell line, with and without palmitate treatment. Epigenomic and transcriptional changes of possible target genes were evaluated by ChIP and quantitative RT-PCR. RESULTS: After long-term feeding with a high-fat diet, C57BL/6J mice were obese and mildly glucose intolerant. Among 39,350 islet cis-regulatory regions, 13,369 and 4610 elements showed increase and decrease in ChIP-Seq signals, respectively, significantly associated with global change in gene expression. Remarkably, increased H3K27ac showed a distinctive genomic localisation, mainly in the proximal-promoter regions, revealing enriched elements for nuclear respiratory factor 1 (NRF1), GA repeat binding protein α (GABPA) and myocyte enhancer factor 2A (MEF2A) by de novo motif analysis, whereas decreased H3K27ac was enriched for v-maf musculoaponeurotic fibrosarcoma oncogene family protein K (MAFK), a known negative regulator of beta cells. By siRNA-mediated knockdown of NRF1, GABPA or MEF2A we found that INS-1 cells exhibited downregulation of fatty acid β-oxidation genes in parallel with decrease in the associated H3K27ac. Furthermore, in line with the epigenome in DIO mice, palmitate treatment caused increase in H3K27ac and induction of β-oxidation genes; these responses were blunted when NRF1, GABPA or MEF2A were suppressed. CONCLUSIONS/INTERPRETATION: These results suggest novel roles for DNA-binding proteins and fatty acid signalling in obesity-induced epigenomic regulation of beta cell function. DATA AVAILABILITY: The next-generation sequencing data in the present study were deposited at ArrayExpress. RNA-Seq: Dataset name: ERR2538129 (Control), ERR2538130 (Diet-induced obesity) Repository name and number: E-MTAB-6718 - RNA-Seq of pancreatic islets derived from mice fed a long-term high-fat diet against chow-fed controls. ChIP-Seq: Dataset name: ERR2538131 (Control), ERR2538132 (Diet-induced obesity) Repository name and number: E-MTAB-6719 - H3K27ac ChIP-Seq of pancreatic islets derived from mice fed a long-term high-fat diet (HFD) against chow-fed controls.
引用
- Nammo T, Udagawa H, Funahashi N, et al. Genome-wide profiling of histone H3K27 acetylation featured fatty acid signalling in pancreatic beta cells in diet-induced obesity in mice. Diabetologia. 2018. PMID: 30284014. doi:10.1007/s00125-018-4735-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。